Wellington Management Group

Wellington Management Group Portfolio holdings

AUM $571B
1-Year Est. Return 25.59%
 

Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+25.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$571B
AUM Growth
+$20.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,105
New
Increased
Reduced
Closed

Top Buys

1 +$2.18B
2 +$1.78B
3 +$1.76B
4
AAPL icon
Apple
AAPL
+$1.65B
5
HD icon
Home Depot
HD
+$1.51B

Top Sells

1 +$3.35B
2 +$2.33B
3 +$1.99B
4
BSX icon
Boston Scientific
BSX
+$1.86B
5
B
Barrick Mining
B
+$1.41B

Sector Composition

1 Technology 26.24%
2 Financials 15.91%
3 Healthcare 14.99%
4 Consumer Discretionary 9.59%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETON icon
1551
Eton Pharmaceutcials
ETON
$456M
$1.92M ﹤0.01%
88,219
+59,006
KOD icon
1552
Kodiak Sciences
KOD
$1.64B
$1.92M ﹤0.01%
117,059
+24,554
CAE icon
1553
CAE Inc
CAE
$9.54B
$1.91M ﹤0.01%
64,650
+1,995
TERN icon
1554
Terns Pharmaceuticals
TERN
$4.58B
$1.9M ﹤0.01%
253,409
-81,760
FTS icon
1555
Fortis
FTS
$29.2B
$1.9M ﹤0.01%
37,506
-6,828
ABEV icon
1556
Ambev
ABEV
$49.3B
$1.9M ﹤0.01%
852,659
-6,810
TBPH icon
1557
Theravance Biopharma
TBPH
$925M
$1.9M ﹤0.01%
130,151
-37,278
BCE icon
1558
BCE
BCE
$24.5B
$1.88M ﹤0.01%
80,283
+65,060
RAPP
1559
Rapport Therapeutics
RAPP
$1.38B
$1.87M ﹤0.01%
+62,822
EWTX icon
1560
Edgewise Therapeutics
EWTX
$3.22B
$1.86M ﹤0.01%
114,531
+1,961
TSHA icon
1561
Taysha Gene Therapies
TSHA
$1.24B
$1.86M ﹤0.01%
568,006
-67,962
BR icon
1562
Broadridge
BR
$21.7B
$1.86M ﹤0.01%
7,795
+334
LU icon
1563
Lufax Holding
LU
$2.25B
$1.85M ﹤0.01%
456,664
-444,708
GIL icon
1564
Gildan
GIL
$12.6B
$1.84M ﹤0.01%
31,764
+1,518
MOMO
1565
Hello Group
MOMO
$1.03B
$1.82M ﹤0.01%
245,225
+226,188
ORIC icon
1566
Oric Pharmaceuticals
ORIC
$1.31B
$1.81M ﹤0.01%
150,594
-72,708
ESPR icon
1567
Esperion Therapeutics
ESPR
$801M
$1.81M ﹤0.01%
+681,294
EMA
1568
Emera Inc
EMA
$15.7B
$1.8M ﹤0.01%
+37,446
CNXC icon
1569
Concentrix
CNXC
$2.01B
$1.79M ﹤0.01%
38,834
+575
INCY icon
1570
Incyte
INCY
$20.2B
$1.79M ﹤0.01%
21,084
-54,781
ZVRA icon
1571
Zevra Therapeutics
ZVRA
$503M
$1.78M ﹤0.01%
187,266
+40,982
LCID icon
1572
Lucid Motors
LCID
$3.24B
$1.78M ﹤0.01%
+74,702
BP icon
1573
BP
BP
$99.5B
$1.77M ﹤0.01%
51,254
-769
ORKA
1574
Oruka Therapeutics
ORKA
$1.67B
$1.75M ﹤0.01%
+91,094
RIGL icon
1575
Rigel Pharmaceuticals
RIGL
$631M
$1.75M ﹤0.01%
61,770
-2,050